FR2707653B1 - Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué. - Google Patents

Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué.

Info

Publication number
FR2707653B1
FR2707653B1 FR9308783A FR9308783A FR2707653B1 FR 2707653 B1 FR2707653 B1 FR 2707653B1 FR 9308783 A FR9308783 A FR 9308783A FR 9308783 A FR9308783 A FR 9308783A FR 2707653 B1 FR2707653 B1 FR 2707653B1
Authority
FR
France
Prior art keywords
conjugate
molecule
biocompatible
pharmaceutical composition
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9308783A
Other languages
English (en)
Other versions
FR2707653A1 (fr
Inventor
Vert Michel
Ustariz Christine
Coudane Jean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetoquinol SA
Original Assignee
Vetoquinol SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol SA filed Critical Vetoquinol SA
Priority to FR9308783A priority Critical patent/FR2707653B1/fr
Publication of FR2707653A1 publication Critical patent/FR2707653A1/fr
Application granted granted Critical
Publication of FR2707653B1 publication Critical patent/FR2707653B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9308783A 1993-07-16 1993-07-16 Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué. Expired - Lifetime FR2707653B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9308783A FR2707653B1 (fr) 1993-07-16 1993-07-16 Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308783A FR2707653B1 (fr) 1993-07-16 1993-07-16 Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué.

Publications (2)

Publication Number Publication Date
FR2707653A1 FR2707653A1 (fr) 1995-01-20
FR2707653B1 true FR2707653B1 (fr) 1995-09-15

Family

ID=9449331

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9308783A Expired - Lifetime FR2707653B1 (fr) 1993-07-16 1993-07-16 Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué.

Country Status (1)

Country Link
FR (1) FR2707653B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE02717541T1 (de) * 2001-05-07 2004-08-26 Cornell Research Foundation, Inc. Biologisch abbaubare copolymere, die an ein segment mit mehreren funktionellen gruppen gebunden sind

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793279A (fr) * 1971-12-30 1973-06-22 Ici Ltd Agents dispersants
DE2824112A1 (de) * 1978-06-01 1979-12-06 Garching Instrumente Mikropellets, verfahren zu ihrer herstellung und deren verwendung
CH663718A5 (de) * 1982-12-17 1988-01-15 Sandoz Ag Pharmazeutische zusammensetzung enthaltend bromokryptin.
JPS62280220A (ja) * 1986-05-29 1987-12-05 Taki Chem Co Ltd 高分子量ポリラクチド又はポリグリコリドの製造法
ES2084688T3 (es) * 1988-12-20 1996-05-16 Jolla Cancer Res Found Conjugados de polipeptido-polimero para el tratamiento de heridas.
US5182045A (en) * 1989-03-29 1993-01-26 The Clorox Company Late peracid precursors
US5028667A (en) * 1989-09-29 1991-07-02 E.I. Du Pont De Nemours And Company Yttrium and rare earth compounds catalyzed lactone polymerization
SE465154B (sv) * 1990-02-06 1991-08-05 Lars Strid Tillvaextfaktor i samband med artificiella transplantat
US5191016A (en) * 1990-07-19 1993-03-02 Manssur Yalpani Functionalized poly(hydroxyalkanoates) and method of manufacturing same

Also Published As

Publication number Publication date
FR2707653A1 (fr) 1995-01-20

Similar Documents

Publication Publication Date Title
CA2304976A1 (fr) Administration de molecules conjuguees a du polyethylene glycol a partir d'hydrogels degradables
WO1988000837A3 (fr) Therapie anticancer novatrice et medicaments cytotoxiques permettant sa mise en oeuvre
CA2312004A1 (fr) Preparation specifique a un site de conjugues de polyethylene glycol-grf
EP1568772A3 (fr) Variants de l'hormone de croissance humaine
TW358031B (en) Drug delivery system for 2 or more active substances
CA2355657A1 (fr) Hydrogels biodegradables thermosensibles/sensibles au ph servant a l'apport prolonge d'agents biologiquement actifs
EP0528035A4 (en) Polyelectrolyte complex antibacterial agent and antibacterial material
WO2001093914A3 (fr) Molecules a plate-forme polyvalentes comprenant un poly(ethylene oxyde) de poids moleculaire eleve
DE69835201D1 (en) Neoglycoproteine
GR3025596T3 (en) Compositions and methods for identifying biologically active molecules.
ATE177657T1 (de) Intravaginales wirkstoffabgabesystem
FI961996A (fi) Pitkitetysti vapauttavat valmisteet metoprololin 24 tunnin pituiseksi vapauttamiseksi
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
IL127976A0 (en) Temperature sensitive gel for sustained delivery of protein drugs
ATE208803T1 (de) Vernetzte copolymere auf der basis von polycarbonsäurepolymeren
FR2719999B1 (fr) Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.
ATE107960T1 (de) Varianten von menschlichem gewebeplasminogenaktivator sowie verfahren zu deren herstellung.
DE69619052D1 (de) Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
FR2707653B1 (fr) Conjugué entre un polymère biocompatible et biodégradable et une molécule notamment une molécule biologiquement active, à hydrogène mobile, son procédé de préparation et composition pharmaceutique comprenant ce conjugué.
BR9810285A (pt) Solução, composição farmacêutica, e, cápsula de gelatina.
BR9004289A (pt) Composicao de composto de hidrogenio ativo-alquileno glicol compatibilizada,polimero de poliuretana e processo para preparar uma composicao de composto de hidrogenio ativo-alquileno glicol compatilizada
NZ515999A (en) Biologically active materials
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
ES2024729A6 (es) Metodo de ensayar muestras desconocidas de fluido biologico para detectar peptidos formadores de canales de iones.
FR2701847B1 (fr) Compositions pharmaceutiques et cosmétiques à base d'albumine végétale, préparations contenant de telles compositions et procédé de préparation.